Pulse Biosciences (PLSE) Amortization of Deferred Charges (2024 - 2025)
Pulse Biosciences' (PLSE) quarterly Amortization of Deferred Charges came in at $306000.0 in Q4 2025, up 20.0% year-on-year from $255000.0 in Q4 2024, and up 5.15% quarter-over-quarter from $291000.0 in Q3 2025.
Pulse Biosciences (PLSE) Amortization of Deferred Charges (2024 - 2025) Analysis & Trends
Pulse Biosciences' Amortization of Deferred Charges history runs 2 years deep, the most recent figure standing at $306000.0 for Q4 2025.
- On a quarterly basis, Amortization of Deferred Charges rose 20.0% year-over-year to $306000.0 in Q4 2025; TTM through Dec 2025 was $1.1 million, a N/A change from a year earlier, with the FY2025 full-year figure at $1.2 million, up 24.92% from the prior year.
- Amortization of Deferred Charges improved to $306000.0 in Q4 2025 per PLSE's latest filing, from $291000.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $306000.0 in Q4 2025 and bottomed at $230000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.74 Bn | 121.52 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 44.89 Bn | 44.07 Bn | 2.15 Bn |
| 3 | Alcon | 33.18 Bn | 31.52 Bn | 1.53 Bn |
| 4 | Medline | 32.90 Bn | 30.67 Bn | 1.84 Bn |
| 5 | Resmed | 29.48 Bn | 27.82 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 23.15 Bn | 22.72 Bn | 329.20 Mn |
| 7 | Solventum | 14.12 Bn | 13.55 Bn | 1.10 Bn |
| 8 | Cooper Companies | 13.87 Bn | 13.73 Bn | 735.40 Mn |
| 9 | Align Technology | 12.17 Bn | 11.11 Bn | 736.59 Mn |
| 10 | Pulse Biosciences | 2.20 Bn | 2.12 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 306,000.00 |
| Dec 31, 2025 | 306,000.00 |
| Sep 30, 2025 | 291,000.00 |
| Sep 30, 2025 | 291,000.00 |
| Dec 31, 2024 | 255,000.00 |
| Dec 31, 2024 | 255,000.00 |
| Sep 30, 2024 | 230,000.00 |
| Sep 30, 2024 | 230,000.00 |